Capital One Financial’s Bristol-Myers Squibb BMY Stock Holding History

Capital One Financial’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,485	Closed	-$903K	–	99
2021 Q4	$903K	Hold	14,485	–	–	0.11%	85
2021 Q3	$857K	Hold	14,485	–	–	0.11%	83
2021 Q2	$968K	Sell	14,485 -25	-0.2%	-$1.63K	0.12%	77
2021 Q1	$916K	Hold	14,510	–	–	0.12%	73
2020 Q4	$900K	Sell	14,510 -6,460	-31%	-$397K	0.12%	79
2020 Q3	$1.26M	Sell	20,970 -547	-3%	-$32.9K	0.16%	74
2020 Q2	$1.26M	Buy	21,517 +946	+5%	+$56.6K	0.17%	91
2020 Q1	$1.15M	Buy	+20,571	New	+$1.26M	0.19%	102

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital One Financial's BMY Position: Q1 2022 in Review

Capital One Financial sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 14,485 shares — an estimated $903K sold.

Capital One Financial first reported a position in BMY in Q1 2020 and held it in 8 quarters. The position peaked at $1.26M in Q2 2020. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

Capital One Financial reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
Capital One Financial sold 14,485 Bristol-Myers Squibb shares in Q1 2022, an estimated $903K.
Capital One Financial first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 8 quarters.
Capital One Financial's Bristol-Myers Squibb position peaked at $1.26M in Q2 2020.
2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on Capital One Financial's 13F filing for Q1 2022, filed 13 Apr 2022.